myAMDteam

The Valeda Light Delivery System is actually the first FDA-authorized treatment specifically for dry AMD. It uses photobiomodulation (specific wavelengths of light) to improve retinal health, reduce inflammation, and enhance visual clarity. Clinical trials showed significant vision improvements, particularly for people with Show Full Answer

The Valeda Light Delivery System is actually the first FDA-authorized treatment specifically for dry AMD. It uses photobiomodulation (specific wavelengths of light) to improve retinal health, reduce inflammation, and enhance visual clarity. Clinical trials showed significant vision improvements, particularly for people with early or intermediate stages of AMD.

The treatment is administered by eye care professionals in short 4-minute sessions, typically scheduled as three sessions per week for three to four weeks (nine sessions total). Regarding safety, clinical trials reported no significant side effects from the Valeda treatment. However, it's important to note that people with advanced stages of AMD (like central geographic atrophy or wet AMD) may not experience the same benefits as those with earlier stage AMD.

As with any treatment decision, it's recommended to discuss this option with your ophthalmologist to determine if it's appropriate for your specific situation and stage of AMD.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Vision-Saving Device for Dry AMD Lands FDA Authorization